logo-loader
Cellmid Ltd

Cellmid Limited outlines key components for FY2020 growth strategy

Cellmid Limited outlines key components for FY2020 growth strategy

Cellmid Ltd -

Cellmid Limited (ASX:CDY) chief executive officer and managing director Maria Halasz updates Proactive Investors on the company’s key components for its FY2020 growth strategy, which includes an exciting new global product to assist ageing hair. 

Cellmid is a listed company with health and biotechnology divisions.

The CEO said Cellmid was thrilled with the progress the company had made since announcing the strategy in February this year, and excited that their main product had received an "outstanding reception" in the market.

Quick facts: Cellmid Ltd

Price: $0.21

Market: ASX
Market Cap: $17.56 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Ltd named herein, including the promotion by the Company of Cellmid Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid is a well funded life sciences company that see a path to profitability

Cellmid (ASX:CDY) Chief Executive and Managing Director Maria Halasz sat down with Christine Corrado from Proactive Investors New York to discuss their biotech company that now has products available in the United States. Halasz telling Proactive they are about to spin out into 2...

on 16/5/19

2 min read